This inventor holds 1 USPTO granted patent. Top assignee: National Central University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Jin-Bor Chen: Innovator in Medical Research
Introduction
Jin-Bor Chen is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of medical research, particularly in the area of encapsulating peritoneal sclerosis. His innovative approach has the potential to improve patient outcomes and enhance diagnostic methods.
Latest Patents
Jin-Bor Chen holds a patent for a method for treating encapsulating peritoneal sclerosis. This method involves estimating the risk for a subject suffering from this condition by measuring the expression level of specific microRNAs from a sample. The microRNAs include miR-17, miR-100, miR-155, miR-202, miR-422a, and miR-483. By comparing the expression levels of these microRNAs in the sample to those of a control, it can be determined if the subject is at risk for encapsulating peritoneal sclerosis. Additionally, he has developed a kit for estimating this risk, which includes agents for identifying the relevant microRNAs from the subject's sample.
Career Highlights
Jin-Bor Chen is affiliated with National Central University, where he conducts his research and development activities. His work has garnered attention for its innovative approach to understanding and diagnosing encapsulating peritoneal sclerosis. With a focus on microRNA expression, his research is paving the way for new diagnostic tools in the medical field.
Collaborations
Jin-Bor Chen collaborates with esteemed colleagues, including I-Kuan Wang and Chiu-Chin Huang. Their combined expertise enhances the research efforts and contributes to the advancement of medical knowledge in their field.
Conclusion
Jin-Bor Chen is a pioneering inventor whose work in medical research is making a significant impact. His patent for a method of estimating risk for encapsulating peritoneal sclerosis showcases his innovative thinking and dedication to improving patient care. Through his collaborations and research at National Central University, he continues to contribute to advancements in medical diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile